Translational Scoring of Candidate Treatments for Alzheimer's Disease: A Systematic Approach.

Dementia and Geriatric Cognitive Disorders
Jeffrey Cummings

Abstract

There are many failures in treatment development for Alzheimer's disease (AD). Some of these failures are the result of development programs that lacked critical information about candidate drugs as these were advanced from one phase of development to the next. Translational scoring (TS) has been proposed as a means of increasing the rigor with which treatment development programs are executed. Previously, these approaches were not specific to AD or to the phase of drug development. Detailed information on the characteristics needed to advance a candidate agent from one phase to the next is the basis for success in subsequent phases. The TS approach is presented with a score range of 0-25 for agents entering phases 1, 2, and 3 of development and those that have completed phase 3 and are being considered for regulatory review. Each phase has 5 essential categories scored from 0-5 indicating the completeness of the data available when the agent is being considered for promotion to the next phase. Lower scores suggest that the development program should be reexamined for missing information while higher scores increase the confidence that the agent has the potential to succeed in the next phase. Scoring guidelines are provided and...Continue Reading

References

Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Dec 14, 2005·European Journal of Clinical Pharmacology·Martin Wehling
Jun 27, 2006·Nature Medicine·Randall J BatemanDavid M Holtzman
Sep 12, 2007·Archives of Neurology·John HarrisonMichael Grundman
Oct 17, 2007·Annual Review of Pharmacology and Toxicology·John A Wagner
Apr 11, 2009·Annals of Neurology·Randall J BatemanDavid M Holtzman
Jun 26, 2009·BMC Neurology·Karen L Steinmetz, Edward G Spack
Jan 5, 2010·Advances in Experimental Medicine and Biology·Mark DayGiora Z Feuerstein
Aug 14, 2010·Current Alzheimer Research·R E Becker, N H Greig
Feb 15, 2011·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Liat PerlmanRoded Sharan
Jul 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Reisa A SperlingRachel J Schindler
Sep 29, 2011·Alzheimer's Research & Therapy·Diana W ShinemanHoward M Fillit
Mar 9, 2012·Journal of Translational Medicine·Alexandra Wendler, Martin Wehling
Apr 26, 2012·Journal of Alzheimer's Disease : JAD·Erik PorteliusRandall J Bateman
Jul 23, 2013·Nature Reviews. Drug Discovery·Robert M PlengeDavid Altshuler
Dec 24, 2013·Neuron·Clifford R Jack, David M Holtzman
Jan 28, 2014·Biochemical Pharmacology·Daniela PuzzoOttavio Arancio
Apr 23, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jessica B LangbaumEric M Reiman
May 17, 2014·Nature Reviews. Drug Discovery·David CookMenelas N Pangalos
May 23, 2014·Lancet Neurology·Bruno DuboisJeffrey L Cummings
Jun 3, 2014·JAMA Neurology·Michael C DonohueUNKNOWN Alzheimer’s Disease Cooperative Study
Jul 16, 2014·Alzheimer's Research & Therapy·Jeffrey L CummingsKate Zhong
Aug 2, 2014·Expert Review of Neurotherapeutics·Francesco PanzaGiancarlo Logroscino
Feb 25, 2015·Annals of Neurology·Adam C KaufmanStephen M Strittmatter
May 1, 2015·Expert Opinion on Drug Discovery·Daniela PuzzoOttavio Arancio
Jul 26, 2015·Neurology·Enchi LiuUNKNOWN Bapineuzumab 301 and 302 Clinical Trial Investigators
Aug 5, 2015·Assay and Drug Development Technologies·Hermann A M Mucke, Eva Mucke
Oct 13, 2015·Drug Discovery Today·Sangeetha De, Linda Meredith
Feb 18, 2016·Alzheimer Disease and Associated Disorders·Jeff SevignyJerome Barakos
Feb 28, 2016·Lancet·Philip ScheltensWiesje Maria Van der Flier
Nov 1, 2014·Forum for Health Economics & Policy·Julie ZissimopoulosPatricia St Clair
Jan 1, 2015·Nature Reviews. Disease Primers·Colin L MastersJeffrey L Cummings
Jul 29, 2016·Science Translational Medicine·Robert M Plenge
Sep 2, 2016·Nature·Jeff SevignyAlfred Sandrock
Dec 13, 2016·Molecular Neurodegeneration·Se Hoon ChoiDoo Yeon Kim
Feb 18, 2017·Nature Reviews. Drug Discovery·Adria TyndallChristopher D Breder
Apr 11, 2017·Trends in Biotechnology·Christopher D BrederAdria Tyndall
May 10, 2017·Journal of Clinical and Translational Science·Daniel G FortJustin B Starren

❮ Previous
Next ❯

Citations

Apr 9, 2021·Journal of Medicinal Chemistry·Michele RossiMaria Laura Bolognesi
Nov 16, 2021·Current Protocols·Michael Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.